19 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
2 May 24
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:09pm
antibody candidate that has been AI-engineered to have increased potency, breadth and resistance to viral escape. The development of VIR-7229 has been
8-K
EX-99.1
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
been AI-engineered to have increased potency, breadth and resistance to viral escape.
◦The development of VIR-7229 has been supported in whole
8-K
EX-99.1
t3qgn9f6 ndlq
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
EX-99.1
wyw9gay86
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
EX-99.2
un834bve7630 ri
28 Jan 21
Other Events
4:05pm
8-K
EX-99.1
7nujjcv0o5xob 5u
10 Nov 20
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
8oq3tk3
16 Sep 20
Other Events
4:07pm
8-K
EX-99.1
1ls4d9kwzeif
11 Aug 20
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:05pm
424B4
y0411umlg6k88yq96ts6
8 Jul 20
Prospectus supplement with pricing info
4:35pm
8-K
EX-99.1
cc2hlthh7n3tck2 vtd
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
0s2in83q4fvx2 29z
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
hm4xfn
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
fiz h362fh
12 May 20
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
10-K
giztn5dtat 015vfr
26 Mar 20
Annual report
4:08pm
8-K
EX-99.1
2ur7qsy5
26 Mar 20
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:01pm
- Prev
- 1
- Next